FDA is also asking that ARS submit additional information on testing for nitrosamine impurities based on new draft guidance that was issued after neffys New Drug Application was submitted in October 2022
They also believe the company should have done more to monitor and report the complications people were experiencing after the drug made it to the market
Clinical trials have shown that GLP-1 medications can help patients lose weight and better control blood sugar, potentially reducing the risk of heart attacks, strokes and other serious health complications
The risks, then, include a sedentary lifestyle, poor diet, obesity or excess weight (especially around the midsection), high blood pressure, high cholesterol, uncontrolled diabetes, smoking, stress, alcohol, and drugs
You might begin to notice subtle changes in your eating patternsfeeling satisfied with smaller portions or experiencing fewer cravings for high-calorie foods